نتائج البحث - "A. Frassoldati"

المساهمون: Del Re, Marzia, Cucchiara, Federico, Rofi, Eleonora, Fontanelli, Lorenzo, Petrini, Iacopo, Gri, Nicole, Pasquini, Giulia, Rizzo, Mimma, Gabelloni, Michela, Belluomini, Lorenzo, Crucitta, Stefania, Ciampi, Raffaele, Frassoldati, Antonio, Neri, Emanuele, Porta, Camillo, Danesi, Romano

مصطلحات موضوعية: immunotherapy, metastatic NSCLC, Liquid biopsy, Biomarkers, Radiomics

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33315149; info:eu-repo/semantics/altIdentifier/wos/WOS:000598702300001; volume:70; issue:6; firstpage:1667; lastpage:1678; numberofpages:12; journal:CANCER IMMUNOLOGY, IMMUNOTHERAPY; http://hdl.handle.net/11392/2447845Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85106622438; https://link.springer.com/article/10.1007/s00262-020-02810-6Test; https://link.springer.com/content/pdf/10.1007/s00262-020-02810-6.pdfTest

الإتاحة: https://doi.org/10.1007/s00262-020-02810-6Test
http://hdl.handle.net/11392/2447845Test

View record in BASE

5

دورية أكاديمية

Immune Checkpoint Inhibitors in "Special" NSCLC Populations: A Viable Approach?

المؤلفون: Bronte, Giuseppe, Cosi, Donato Michele, Magri, Chiara, Frassoldati, Antonio, Crinò, Lucio, Calabrò, Luana

المصدر: International Journal of Molecular Sciences; Aug2023, Vol. 24 Issue 16, p12622, 20p

مصطلحات موضوعية: IMMUNE checkpoint inhibitors, BIOMARKERS, NON-small-cell lung carcinoma, THERAPEUTICS, PATIENT selection

النص الكامل

6

دورية أكاديمية

Prospective biomarker analysis of the randomized CHER-LOB study evaluating the dual anti-HER2 treatment with trastuzumab and lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive breast cancer

المؤلفون: Guarneri, Valentina, Dieci, Maria Vittoria, FRASSOLDATI, Antonio, Maiorana, Antonino, Ficarra, Guido, Bettelli, Stefania, Tagliafico, Enrico, Bicciato, Silvio, Generali, Daniele Giulio, Cagossi, Katia, Bisagni, Giancarlo, Sarti, Samanta, Musolino, Antonino, Ellis, Catherine, Crescenzo, Rocco, Conte, Pierfranco

المساهمون: Guarneri, Valentina, Dieci, Maria Vittoria, Frassoldati, Antonio, Maiorana, Antonino, Ficarra, Guido, Bettelli, Stefania, Tagliafico, Enrico, Bicciato, Silvio, Generali, Daniele Giulio, Cagossi, Katia, Bisagni, Giancarlo, Sarti, Samanta, Musolino, Antonino, Ellis, Catherine, Crescenzo, Rocco, Conte, Pierfranco

مصطلحات موضوعية: Breast neoplasms, Gene expression profiling, Molecular targeted therapy, Neoadjuvant therapy, p95-HER2, PIK3CA, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Chemotherapy, Phosphatidylinositol 3-Kinases, Quinazolines, Receptor, ErbB-2, Trastuzumab

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/26245675; info:eu-repo/semantics/altIdentifier/wos/WOS:000360975000009; volume:20; issue:9; firstpage:1001; lastpage:1010; numberofpages:10; journal:THE ONCOLOGIST; http://hdl.handle.net/11392/2377790Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84940646917

الإتاحة: https://doi.org/10.1634/theoncologist.2015-0138Test
http://hdl.handle.net/11392/2377790Test

View record in BASE

7

دورية أكاديمية

Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR

المؤلفون: Mangolini Alessandra, FERRACIN, MANUELA, Zanzi Maria Vittoria, Saccenti Elena, Ebnaof Sayda Omer, Poma Valentina Vultaggio, Sanz Juana M., Passaro Angela, Pedriali Massimo, Frassoldati Antonio, Querzoli Patrizia, Sabbioni Silvia, Carcoforo Paolo, Hollingsworth Alan, Negrini Massimo

المساهمون: Mangolini Alessandra, Ferracin Manuela, Zanzi Maria Vittoria, Saccenti Elena, Ebnaof Sayda Omer, Poma Valentina Vultaggio, Sanz Juana M., Passaro Angela, Pedriali Massimo, Frassoldati Antonio, Querzoli Patrizia, Sabbioni Silvia, Carcoforo Paolo, Hollingsworth Alan, Negrini Massimo

مصطلحات موضوعية: Breast cancer, Circulating miRNA, Diagnostic marker, Prognostic marker, Droplet digital PCR, BLOOD-BASED MARKERS, CIRCULATING MICRORNA, QUANTIFICATION, METASTASIS, IDENTIFICATION, BIOMARKERS, PLASMA, MIRNAS

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/26120471; info:eu-repo/semantics/altIdentifier/wos/WOS:000361109500001; volume:3; firstpage:1; lastpage:9; numberofpages:9; journal:BIOMARKER RESEARCH; http://hdl.handle.net/11585/542220Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85087720867; http://www.biomarkerres.org/content/3/1/12Test

الإتاحة: https://doi.org/10.1186/s40364-015-0037-0Test
http://hdl.handle.net/11585/542220Test
http://www.biomarkerres.org/content/3/1/12Test

View record in BASE

8

Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials

المؤلفون: Maria Vittoria Dieci, Aicha Goubar, Giancarlo Bisagni, Gaia Griguolo, Daniele Generali, Valentina Guarneri, A. Michelotti, Antonio Frassoldati, Rossana Berardi, Fabio Puglisi, Guido Ficarra, Katia Cagossi, Federico Piacentini, Giuseppe Luigi Banna, Pierfranco Conte, Luigi Cavanna

المساهمون: Dieci, M. V., Frassoldati, A., Generali, D., Bisagni, G., Piacentini, F., Cavanna, L., Cagossi, K., Puglisi, F., Michelotti, A., Berardi, R., Banna, G., Goubar, A., Ficarra, G., Griguolo, G., Conte, P., Guarneri, V.

المصدر: Breast Cancer Research and Treatment. 163:295-302

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, Receptor, ErbB-2, medicine.medical_treatment, Tumor-infiltrating lymphocytes, law.invention, ErbB-2, 0302 clinical medicine, Randomized controlled trial, law, Chemotherapy, Endocrine therapy, Ki67, Neoadjuvant, Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Breast Neoplasms, Chemotherapy, Adjuvant, Female, Humans, Lymphocytes, Tumor-Infiltrating, Middle Aged, Neoadjuvant Therapy, Nitriles, Prospective Studies, Quinazolines, Receptors, Cell Surface, Treatment Outcome, Triazoles, Receptors, 80 and over, Lymphocytes, Prospective cohort study, Adjuvant, Neoadjuvant therapy, Tumor, 030220 oncology & carcinogenesis, Letrozole, Cell Surface, Cohort, Nitrile, Breast Neoplasm, Human, Receptor, medicine.drug, medicine.medical_specialty, Socio-culturale, Tumor-infiltrating lymphocyte, Lapatinib, 03 medical and health sciences, Breast cancer, Internal medicine, medicine, Tumor-Infiltrating, Antineoplastic Combined Chemotherapy Protocol, business.industry, Quinazoline, medicine.disease, Prospective Studie, 030104 developmental biology, Triazole, business, Biomarkers

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f604f4d4f49637b5de0deb2bdbe66acbTest
https://doi.org/10.1007/s10549-017-4191-yTest

9

دورية أكاديمية

A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation

المصدر: The Lancet Oncology, 21(11)

العلاقة: https://doi.org/10.17615/hpvv-f686Test; https://cdr.lib.unc.edu/downloads/9k41zp25v?file=thumbnailTest; https://cdr.lib.unc.edu/downloads/9k41zp25vTest

الإتاحة: https://doi.org/10.17615/hpvv-f686Test
https://cdr.lib.unc.edu/downloads/9k41zp25v?file=thumbnailTest
https://cdr.lib.unc.edu/downloads/9k41zp25vTest

View record in BASE

10

Association of systemic inflammation index and body mass index with survival in patients with renal cell cancer treated with nivolumab

المساهمون: De Giorgi, U, Procopio, G, Giannarelli, D, Sabbatini, R, Bearz, A, Buti, S, Basso, U, Mitterer, M, Ortega, C, Bidoli, P, Ferraù, F, Crinò, L, Frassoldati, A, Marchetti, P, Mini, E, Scoppola, A, Verusio, C, Fornarini, G, Cartenì, G, Caserta, C, Sternberg, C

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, PROGNOSIS, PRETREATMENT NEUTROPHIL, Kaplan-Meier Estimate, TO-LYMPHOCYTE RATIO, TARGETED THERAPY, CARCINOMA, CHEMOTHERAPY, EVEROLIMUS, SUNITINIB, MODEL, Severity of Illness Index, Body Mass Index, 0302 clinical medicine, Antineoplastic Agents, Immunological, Renal cell carcinoma, Molecular Targeted Therapy, Prospective cohort study, Aged, 80 and over, Univariate analysis, Middle Aged, Kidney Neoplasms, Nivolumab, Treatment Outcome, 030220 oncology & carcinogenesis, Female, Adult, medicine.medical_specialty, renal cell carcinoma, Socio-culturale, 03 medical and health sciences, Internal medicine, medicine, Humans, Risk factor, Carcinoma, Renal Cell, Aged, Neoplasm Staging, Inflammation, Performance status, business.industry, medicine.disease, 030104 developmental biology, Expanded access, business, Body mass index, Biomarkers

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b51d4048a58b0ed8e5867c52acbf50eTest
http://hdl.handle.net/10281/260646Test

تنقيح النتائج